Injection of new psychoactive drugs in Romania multi-indicator analysis
|
|
- Calvin Melton
- 5 years ago
- Views:
Transcription
1 Injection of new psychoactive drugs in Romania multi-indicator analysis Psycho-Sociologist Lavinus Sava - RNAA LISBON October 2013
2 Romania, stabilization of drug phenomenon in Romania, both in terms of demand and supply (after 3 years of changes: reorganizing the NAA and the NPS outburst) The (epidemic) outbreak of HIV infection among the IDUs notified since two years ago continues. (31% of all new reported HIV infected cases comes from the IDUs National Comision for fighting against AIDS, within Health Ministry) The NPS still the main problem in sight for the antidrug public policy system.
3 DATA SOURCES Recent studies/projects PDU estimates Key and core indicators (TDI, DRID, DRD, non-fatal drug emergencies) Supply indicators ROUTINE MONITORING of the implementing of the National program of measures to combat the marketing and use of new psychoactive substances / products harmful to health
4 PDU estimates an estimated number of 19,265 (95% CI: 14,564 26,296) problem drug users in Bucharest (1967 clients of treatment services for intensive use of opioids, NPS, cocaine and amphetamines) cases of IDUs in treatment (heroin- 823/ 74,2% cases and NPS- 247/25,8% cases reporting almost all the use of metamphetamihe-like substance called PURE) 4
5 NAA/ARAS/CARUSEL PROJECT The NAA set up a harm-reduction pilot project in 2012, distributing syringes to the IDUs from Bucharest, using the facilities of two partner NGOs : ARAS and CARUSEL. The analysis of the data collected through this program (may- december 20120) indicates: 1326 IDUs registered (60% by ARAS, 40% by Carusel) 3934 contacts to the NSP units (87,4% to the 3 drop-in centers and 12,6% to the mobile outreach teams) an average of 3 contacts/client. 78% of the clients are male clients. the most prevalent age group was the years one. all of the clients registered are IDUs, 3,4% declare themselves sex workers, 15,7% are homeless, almost 1% are street children and 47% are roma people 51% are NPS injecting users, 44% are heroin users and 5% injects both NPS &Heroin. 5
6 Lifetime prevalence of illicit drugs droguri ilicite/ NPS -data from studies ( )- ESPAD years SPS 18 years YPS years GPS years Any drug /substance 10 23,2 11,7 9,5 From which SNPP 5,3 9,5 6,0 4,1 COCAINE 2 1,6 0,5 0,5 AMPHETAMINE 3 1,4 0,4 0,1 HEROIN 1 0,3 0,8 0,4
7 * Risks Assessment of the use of new psychoactive substances among children and young people in Romania, Behaviour patterns of the legal highs intensive users: age: years old (significant use at children < 15 years old); high visibility of use; socially integrated youngsters coming from normal families; low adressability to medical/social services. 2. Frequency of use 42,5% - first drug used is NPS /daily basis use, 24,2% -once at every 3 days, 25% - between 4 and 10 uses in the past 30 days, 8,3% < 4 uses in the past 30 days. 3.Poly-drug use 55,9% - have used some other legal products in the past 30 days. (1 of 10 respondents declares frequent use of illicit drugs either). They also use : alcohol, heroin, amphetamine, cocaine, diazepam, valium, rofedex, marijuana, prenadez, tusin. 4. History of use Varies between 1 and 31 months, with an average of 13 months, most frequent answer recorded is 24 months, or 2 years. 5.Administration route Smoking, followed by injecting and sniffing. NPS patterns of use(1)* 7
8 TDI clients were assisted in 2012 (in and out patient treatment) for alcohol, tobacco and illicit drugs & NPS use (3362 in 2011): illicit drugs- 1528/43,64% and NPS 685 /19,56% (36% of them are registered as injecting users). 232 convicted drug users were assisted in prison (227 for illicit drugs & NPS use) 8
9 2012 reversed trend - heroin users are more prevalent; The NPS are less used as primary drug and more like a secondary one, together with alcohol and cannabis. (23,7% cases of NPS as secondary drug) Sex: higher percentage of male users for backslidings (51,1% vs. 38,7%),also for assistance provided to them in opiate use (39,5% vs. 32,2%), NPS use (36,2% vs. 17,8%) and canabis use (12,9% vs. 6,1%) User s age the most of those assisted for NPS use in 2012 were from the years age group (75,9%). Onset age - the most prevalent onset age is years for the opiates users and years for NPS ; It raises the percentage of the < 15 years opiates first time users and < 19 years NPS first time users. 9
10 Illicit and NPS admissions by usual route of administration (%)) Incidence a decreasing trend of the injecting use and sniffing and increase of the smoking/inhalling and oral use. 10
11 DRID increasing trend Alarming rise for HVB; Rise for HVC at high level (over EU average); Alarming rise for the HIV (over EU average). Posible causes: Harm-reduction services offer seriously diminished after the ending of some UN funded programmes. The injecting frequency increased because of the new patterns of use and swapping from opiates to NPS injecting use. Low rates of adresability to medical/social services. 11
12 HVB : Stabilization of the HVB prevalence among the male users (from 25,6% to 26%), but a significant increase of the HVB prevalence among the female ones (from 4,4% to 17,7%). the highest prevalence of HVB was registered among the IDUs from the years age group (26,8%). HVC: 82,4% HVC prevalence in 2012 (68,5% in 2011) - România enters the top of the European countries with high prevalences of HVC. HVC prevalence is significantly higher among male users 85,4%, compared to the females 65,5%. It is also noticed an increase of the females HVC positive. It increases the HVC prevalence for al the IDUs age groups. 12
13 HIV: 89 cases (24,5%) of seropositives IDUs from all the 358 IDUs tested for HIV in the privious 6 months. - 3 times higher than one year before. the most spectacular increase of HIV prevalence is registered for the < 25 years age group (over 6 times higher compared to 2011) Health Ministry reports 231 new cases of HIV infected IDUs in 2012 (31% of all new HIV cases for all the risk cathegories). The increasing trend continues to maintain, showing a possible HIV epidemic outbreak in the near future. The BSS 2012 still in progress - preliminary data indicates an HIV prevalence among IDUs of 52,5%. 13
14 Medical Emergencies after the NPS use, 2012 more than 2/3 of teh emergencies registered for drugs use are for NPS. 90,5% of the cases are <34 years. 10 years NPS users registered by the emergency medical units. NPS reported for 10 of the 133 suicide attempts registered. NPS use related deaths are first time mentioned in 2012 by the emergency units (6 indirect deaths). Polydrug use * Injecting use Crosstabulation Injecting use Not injecting Injecting Total Polydrug use nu Count % within Polydrug use 75,9% 24,1% 100,0% da Count % within Polydrug use 67,5% 32,5% 100,0% Total Count % within Polydrug use 73,6% 26,4% 100,0% 14
15 Geographical Spreading of the NPS Risk areas defined by the share of the non-fatal emergency related to NPS use
16 DRD, direct drug related deaths registered (all from Bucharest, all with positive toxicologic tests) 16 indirect related to drug use deaths registered 3 DDRD due to acute intoxication with NPS ; 2 IDRD were NPS are suspected, in association with some other illicit drugs Decese direct asociate Decese indirect asociate Significant decrease of the average age when dying - 28,03 years for DDRD and 26,56 for IDRD 16
17 NPS influence on indirect death cases radical change of the pattern of the substances used and administration practices: -very frequent administration from 6 to 8 times a day, especially for the IDUs. -rapid change from ingestion/smoking to injecting use. high availability/low price/ legal status/ perceived as low risk drugs. relatively limited potency (low risk of immediate and lethal overdose compared with the illicit drugs)/ highly addictive. unknown composition, highly contaminated street doses, paraphernalia used in common with others, infectious pathology with acute evolutions. they are not generating death by themselves (only 3 direct drug related deaths recorded for NPS use in 2012) - generate accelerated pathologies that lead to death by medical complications not by overdose. 17
18 RESPONSES -impact of public policies controlling measures Several government decisions were adopted in order to put under national legal control the marketing and use of some NPS (43 of them were enlisted) but the most important in terms of impact is the Law 194/November 2011(to combat any operation with new substances susceptible of having psychoactive effects). The National program of measures to combat the marketing and use of new psychoactive substances / products harmful to health adopted in february The mixed inter-institutions controlling teams were set at local level, and their work within the framework of this program have led to some visible results. NAA & partner NGOs national and local NPS use prevention campaigns (THE ABSENT 2011; TOO REBEL TO BE LED (by drugs) 2012 NAA distributed to the partner NGOs from the RHRN syringes and bought some other syringes to be distributed to the NSP in 2013.
19 SUPPLY INDICATORS NUMBER OF SEIZURES AND QUANTITIES significant seizures of NPS (synthetic cannabinoids JWH-018) originated from Spain and reaching Romania via France Germany Austria Hungariy 2012 significant decrease of the NPS quantities sized (1,5 Kg), compared to 2010 (125,14 kg) and 2011 (4,96 kg). SNPP Cantitate capturată Număr capturi kilograme comprimate Canabinoizi sintetici 57,024 2,865 1, Catinone 50,091 1,863 0, Piperazine 6,506 0,023 0, Pirovalerone 1, , Triptamine 8,932 0,015 0, Mitragin 0,139 0, Salvinorin 0,648 0, Dimetocaină 0 0 0, Tabel nr. 2-4: Confiscările de substanţe noi cu proprietăţi psihoactive (kg) în perioada Sursa: Laboratorul central de analizăşi profil al drogurilor, Inspectoratul General al Poliţiei Române
20 ROUTINE MONITORING of the implementing of the National program of measures to combat the marketing and use of new psychoactive substances / products harmful to health EVOLUTION OF THE NUMBER OF IDENTIFIED /CONTROLLED DREAM-SHOPS FEBRUARY - MARch feb apr iun aug oct dec Nr. magazine identificate feb.12 apr.12 iun.12 aug.12 oct.12 Nr. magazine controlate Decembrie 2012 feb.13 20
21 CONCLUSIONS 1.The new laws (Law no. 194/2011 and COM no. 103/2012) had great effect in stopping the trade of the NPS in the head-shops (all were closed), but the illicit market (on/line market) keep on supplying the consumers. 2. Significant decrease of NPS seizured in the last 2 years 3.INJECTING NPS use and the harm-related issues: High levels of prevalence for HIV and HBV/HVC among the injectors of the NPS. High numbers of the medical emergencies related to NPS use (2/3 of the emergency cases related to drug use were consequences of NPS use 67%) DRD to NPS use appeared (3 direct deaths in 2012 / 2 cases in 2011) 21
22
23 23
The evolution of the HIV/AIDS outbreak among IDUs in Romania
The evolution of the HIV/AIDS outbreak among IDUs in Romania Romanian National Antidrug Agency Romanian National Focal Point on Drugs Andrei Botescu * Lisbon, 12 th October 2012 HIV outbreak among IDU
More informationConsumption of new substances with psychoactive effects (NSPE)
Consumption of new substances with psychoactive effects (NSPE) Aurora LEFTER, sociologist Bogdan GHEORGHE, MD LISBON 20-21 SEPTEMBER 2012 Survey Risks Assessment of the use of new psychoactive substances
More informationHIV/AIDS Think Tank meeting: EMCDDA report. Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015
HIV/AIDS Think Tank meeting: EMCDDA report Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015 European Drug Report 2015 Drop o Trends in seizures by substance from 2009 o Drug and related long-term
More information2 nd Meeting on detecting and responding to outbreaks of HIV among PWID
2 nd Meeting on detecting and responding to outbreaks of HIV among PWID Update on country situation: ROMANIA Adrian Abagiu* & Andrei Botescu** *Romanian Association Against AIDS (ARAS) and National Institute
More informationAnnual report 2009: the state of the drugs problem in Europe
Annual report 2009: the state of the drugs problem in Europe Alessandro Pirona, Rome 05/11/2009 European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Established: 1993 Seat: Lisbon Staff: 100
More informationRapporteur report of Session 2: New Trends in TDI clients. Thursday, September 20th 2012, ( Room 106) Chair: Dragica Katalinic
Rapporteur report of Session 2: New Trends in TDI clients Thursday, September 20th 2012, (14.30 16.00 Room 106) Chair: Dragica Katalinic Rapporteur: Christine Marchand-Agius 1. Presentation on new trends
More informationNew patterns of drug use in Hungary
New patterns of drug use in Hungary Gergely Horváth Hungarian National Focal Point PDU Annual Expert Meeting 2012 Lisbon, 25-26 September 2012 First glance From 2009 on decrease in heroin availability,
More informationWorkshop summary. Exchange on data collection challenges related to new psychoactive substances use. Presentation of the situation
Workshop summary Presentation of the situation Among countries participating in the workshop the level and characteristics of NPSs use showed great diversity. The use and the problem use of NPSs is a major
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-FIFTH REGULAR SESSION April 29 - May 1, 2014 Washington, D.C. OEA/Ser.L/XIV.2.55 CICAD/doc.2089/14
More informationTrends in injecting drug use in Europe
Trends in injecting drug use in Europe Linda Montanari, Bruno Guarita and Danica Thanki Annual Expert Meeting on Drug-Related Infectious Diseases Lisbon, 15-17 October Overview of the presentation 1) Information
More informationAnnual report 2012: the state of the drugs problem in Europe
Annual report 2012: the state of the drugs problem in Europe Ilze Jekabsone, MD, MPH Reitox and international cooperation unit 14 December 2012 2 Setting the scene After 30+ years with heroin centre stage
More informationInjecting trends in Austria including results of a systematic literature review on interventions aiming to influence the route of administration
Injecting trends in Austria including results of a systematic literature review on interventions aiming to influence the route of administration Alexander Grabenhofer-Eggerth TDI expert meeting - Lisbon,
More informationDrug consumption among roma population
NATIONAL ANTIDRUG AGENCY Drug consumption among roma population High risk drug use and drug treatment in Europe 2014 Special populations and drug problems Lisbon, 24 September 2014 General characteristics
More informationOverview of drug-induced deaths in Europe - What does the data tell us?
Overview of drug-induced deaths in Europe - What does the data tell us? João Matias, Isabelle Giraudon, Julián Vicente EMCDDA expert group on the key-indicator Drug-related deaths and mortality among drug
More informationMost recent data, analyses and feed-back from the 2016 DRID national updates
Most recent data, analyses and feed-back from the 216 DRID national updates Eleni Kalamara, Dagmar Hedrich, Linda Montanari, Isabelle Giraudon 15-16 June 217, Lisbon DRID/TDI annual expert meeting DRID
More informationEMCDDA-update HIV/HCV among people who inject drugs: situation and response
EMCDDA-update HIV/HCV among people who inject drugs: situation and response Dagmar Hedrich EU Think Tank HIV/AIDS: 24-25 November 2015, Luxembourg Latest European overview Multi-indicator based analysis
More informationPOLICY, LEGISLATION, ECONOMIC ANALYSIS AND MEDIA COVERAGE. Last data available Indicator (sphere)
POLICY, LEGISLATION, ECONOMIC ANALYSIS AND MEDIA COVERAGE Amendments in laws and legal regulations number 8 2 NDC Expenditures for activities against drugs and drug addictions in Bulgaria [1] BGN 1 102
More informationTrends in cannabis use and cannabis-related treatment demand in Switzerland
Trends in cannabis use and cannabis-related treatment demand in Switzerland Etienne Maffli, Addiction Switzerland, Lausanne TDI and HRDU annual expert meetings, Lisbon, sept. 23-26 2014 Data sources available
More information2011 NATIONAL REPORT (2010 data) TO THE EMCDDA by the Reitox National Focal Point ROMANIA
European Monitoring Centre for Drugs and Drug Addiction National Anti-drug Agency 2011 NATIONAL REPORT (2010 data) TO THE EMCDDA by the Reitox National Focal Point ROMANIA New Developments, Trends and
More informationThe issues facing Europe
The issues facing Europe An overview Andrew Cunningham Supply reduction and New Drugs unit 28 May 2015 European Drug Report 2015 https://youtu.be/vzzyp3k6psk 2 Opiates (heroin) Europe s main drug issue
More information2 nd Meeting on detecting and responding to outbreaks of HIV among PWID
2 nd Meeting on detecting and responding to outbreaks of HIV among PWID Update on country situation: AUSTRIA Lisbon, 12 th October 201 Epidemiological update 2 HIV notifications in PWID Number of HIV cases
More informationPoland nationalupdate
Poland nationalupdate 16th October 2014 Annual expert meeting on Drug-related deaths (DRD) and Drug-related infectious diseases (DRID) Estimation of HIV and HCV prevalence among injecting drug users in
More informationAnnual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use
Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use Report of the Government of: Reporting Year: Completed on (date): Please return completed questionnaire to: arq@unodc.org
More informationNPS use, harms and health responses to NPS in Europe: findings form multi-method studies
NPS use, harms and health responses to NPS in Europe: findings form multi-method studies Alessandro Pirona Brussels, September 2017 NPS & public health responses Set the scene by providing a brief update
More informationThe Polish legislation on smart shops
The Polish legislation on smart shops New Drugs 2014 Scientific and technical update on New Psychoactive Substances May 14th-15th, 2014 Rome Michał Kidawa REITOX National Focal Point Poland Presentation
More informationNew trends in harm reduction in Europe: progress made challenges ahead
New trends in harm reduction in Europe: progress made challenges ahead Dagmar Hedrich, Alessandro Pirona, EMCDDA 2 nd European Harm Reduction Conference, 7-9 May 2014, Basel Session 4: Changes in harm
More informationPublic consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs
Case Id: a79a0e63-798e-4bb8-9bac-4d373def86d2 Date: 07/03/2016 12:50:57 Public consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs Fields marked with are mandatory. Please
More informationINTRAVENOUS INJECTING DRUG USE.
Injecting drug users in Europe Towards an educational approach Lucas Wiessing European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon lucas.wiessing@ emcdda.org www.emcdda.org It has been
More informationFirst results collected by Argos, DCR in Strasbourg opened in november 2016
Photo Marine Saiah First results collected by Argos, DCR in Strasbourg opened in november 2016 Danièle BADER, Leader of Ithaque Association EMCDDA, DRID Meeting 18-20 september 2017 A crossborder experimentation
More informationChanges in the NPS market in Eastern and Central Europe
Changes in the NPS market in Eastern and Central Europe ESSD 27th Annual Conference Frankfurt, 22-24 September 2016 Agnese Zile-Veisberga Artur Malczewski Outline Methodology; Description of the NPS market
More informationPerspectives for information on alcohol use in the EU
EMCDDA Perspectives for information on alcohol use in the EU Julian Vicente Luxembourg 20-21 March 2018 CNAPA meeting Topics in this presentation ESPAD project (now with EMCDDA) in students Alcohol ( Tobacco
More informationThe forgotten group: a new HIV outbreak amongst people who inject drugs. Patricia Anderson Lead CNS BBV Brownlee Centre
The forgotten group: a new HIV outbreak amongst people who inject drugs Patricia Anderson Lead CNS BBV Brownlee Centre No conflicts to declare Potted History 1981 Modern wave of drug misuse Glasgow soared
More informationNEEDLE AND SYRINGE PROGRAMMES MONITORING IN LITHUANIA
NEEDLE AND SYRINGE PROGRAMMES MONITORING IN LITHUANIA Dr. Audronė Astrauskienė Drug control department under the Government of the Republic of Lithuania 2010 10 25 Harm reduction services development in
More informationHIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications
HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications Don Des Jarlais, Ph.D. Professor of Psychiatry, Icahn School of Medicine at Mount Sinai UNODC 2014
More informationPublic drug policies Catalonia
Public drug policies Catalonia Public Health Agency of Catalonia Xavier Majó Roca Catalonia Barcelona Territory: 32.000 km2 Population: 7.523.000 M Own language and culture 1. What s happened in Catalonia
More informationGlobal drug trends and sustainable development
Lau Global drug trends and sustainable development Chloé Carpentier Chief, Drug Research Section UNODC Göteborg, 15 November 2017 Global trends in estimated number of drug users and people with drug user
More informationWorld Drug Report 2017
World Drug Report 2017 DEMAND Global trends in estimated number of drug users and people with drug user disorders, 2006-2015 Global trends in the estimated prevalence of drug use and prevalence of people
More informationFocal Point Ireland: national report for 2016 Drugs Ireland
Focal Point Ireland: national report for 206 Drugs Ireland Health Research Board. Irish Focal Point to the European Monitoring Centre for Drugs and Drug Addiction Authors of the national report Margaret
More informationClaire Gilbert, Tony Margetts, Gilda Nunez, Bryony Sedgwick, Tim Allison. Thanks to Hull Public Health, Prof. Marks and Paul Smith
There is something in the heroin: responding to a rise in drug related deaths and the emergence of fentanyl and carfentanil in a local illicit drug market Claire Gilbert, Tony Margetts, Gilda Nunez, Bryony
More informationWhat is Drug Trends? funded by the Australian Government under the Substance Misuse Prevention and Service Improvement Grants Fund
What is Drug Trends? funded by the Australian Government under the Substance Misuse Prevention and Service Improvement Grants Fund Outline How do we monitor drug trends in Australia Aims Methodology Drug
More informationImproving our capacity of identification and reporting on emerging trends. New methods and new areas of analysis
Improving our capacity of identification and reporting on emerging trends New methods and new areas of analysis Monitoring challenges Rapidly changing, globalised drug market Growth of online and virtual
More informationTaking Stock of the 2009 PoA Research and Trend Analysis Branch
Taking Stock of the 2009 PoA Research and Trend Analysis Branch Eliminate or reduce significantly and measurably: The five targets Illicit cultivation of opium, coca, cannabis Illicit demand of drugs and
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-FIFTH REGULAR SESSION April 29 - May 1, 2014 Washington, D.C. OEA/Ser.L/XIV.2.55 CICAD/doc.2094/14
More informationBulgaria Bulgaria Drug Report 2018
Bulgaria Bulgaria Drug Report 218 This report presents the top-level overview of the drug phenomenon in Bulgaria, covering drug supply, use and public health problems as well as drug policy and responses.
More informationFACT SHEET SERBIA (REPUBLIC OF)
FACT SHEET SERBIA (REPUBLIC OF) Territory: Borders: 88,509 sq. km 2,362 km (total) Hungary: 175 km, Romania: 548 km, Bulgaria: 361 km, FYR of Macedonia: 283 km, Albania: 114 km, Montenegro: 249 km, Bosnia
More informationSession I. Update on synthetic cathinones injection in Hungary
Session I. Update on synthetic cathinones injection in Hungary Róbert Csák Hungarian National Focal Point High risk drug use and drug treatment in Europe 2014 EMCDDA event: Continuity and Change Lisbon,
More informationJSNA Substance Misuse
JSNA Substance Misuse Introduction 9.1. Substance misuse causes less damage to health in absolute population terms than tobacco or alcohol. However, its association with crime and antisocial behaviour
More informationResults from the NPSinEurope.eu Project 5-Country RAR of New Psychoactive Drugs (NPS)
Results from the NPSinEurope.eu Project 5-Country RAR of New Psychoactive Drugs (NPS) Grund, Jean-Paul Vavrinčíková, Lenka Janíková, Barbara Fidesová, Hana Health responses to NPS EMCDDA, Lisboa. 28-10-2015
More informationPublic consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs
Case Id: 72f3c8af-e4e6-438f-87c8-fea4174490b8 Date: 27/05/2016 10:40:37 Public consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs Fields marked with are mandatory. Please
More informationRecent trends in drug problems and service provision in Greece
Recent trends in drug problems and service provision in Greece Anastasios Fotiou Epidemiology Unit The Greek Reitox focal point of the EMCDDA at the Understanding the dynamics, nature and scale of drug
More informationFACT SHEET TAJIKISTAN (REPUBLIC OF)
FACT SHEET TAJIKISTAN (REPUBLIC OF) Territory: 142,600 sq. km. Source: Tajikistan in Figures 2014, Agency on Statistics under the President of the Republic of Tajikistan, 2014 Borders: Afghanistan - 1,344
More informationTDI 3.0 implementation. TDI Prevalence. Linda Montanari, Bruno Guarita
TDI 3.0 implementation TDI Prevalence Linda Montanari, Bruno Guarita Lisbon, 21 22 September 2015 Workshop 3.0 The role and value of data from drug treatment services (TDI working group) TDI implementation
More informationStrategies of drug users to avoid infection with hepatitis C
With financial support from the Drug Prevention and Information Programme of the European Union Strategies of drug users to avoid infection with hepatitis C Results from five European countries Dr. Heike
More informationEMCDDA trend report for the evaluation of the EU drugs strategy
EMCDDA trend report for the evaluation of the 2005 12 EU drugs strategy Contents Executive summary...4 Drug use and drug-related problems...4 Drug supply and new drugs...6 Drug policies...7 Demand reduction...8
More informationU.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs
U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs Michelle Van Handel, MPH Health Scientist National Center for HIV/AIDS, Viral Hepatitis, STDs and
More informationThe Netherlands Drug Situation Summary
The Netherlands Drug Situation 2010 - Summary Developments in drug law and policies (chapter 1) The intended new Dutch drug policy was delayed because the Dutch government fell in February 2010. The resigned
More informationPublic consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs
Case Id: d79bf7da-998d-4fa4-b202-bac606c39a58 Date: 29/04/2016 09:21:26 Public consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs Fields marked with are mandatory. Please
More informationFACT SHEET 1 IRAN (ISLAMIC REPUBLIC OF)
FACT SHEET 1 IRAN (ISLAMIC REPUBLIC OF) Territory: Borders: 1,648,195 sq. km. Azerbaijan (432 km/268 mi) and Armenia (35 km/22 mi) to the north-west; Turkmenistan (992 km/616 mi) to the north-east; Pakistan
More informationCombination of various data bases and estimation methods to better estimate the market from the demand and the supply side and consequences
EU project JUST/2010/DPIP/AG/1410: New methodological tools for policy and programme evaluation, www.drugpolicyevaluation.eu Combination of various data bases and estimation methods to better estimate
More informationWORLD DRUG REPORT 2011
WORLD DRUG REPORT 2011 EXECUTIVE SUMMARY Global developments in illicit drug consumption, production and trafficking Consumption Globally, UNODC estimates that, in 2009, between 149 and 272 million people,
More informationIllicit drug use in prisons
Illicit drug use in prisons. Kieran Lynch Criminal Justice Programme Manager.PHE (Acknowledgements: Dr. George Ryan Criminal Justice Clinical Lead for PHE) Key Themes The drugs The people Update on Opiate
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
1 INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-SECOND REGULAR SESSION November 28-30, 2012 San José, Costa Rica OEA/Ser.L/XIV.2.52 CICAD/doc.1988/12
More informationRecent developments in the detection of harms arising from the use of synthetic cathinonesin Europe
No conflict of interest Recent developments in the detection of harms arising from the use of synthetic cathinonesin Europe Ana Gallegos 24 September 2015 Lisbon Addictions Conference 2015 Paper session
More informationHarms and harm reduction workbook. Country X
Harms and harm reduction workbook Country X 1 Table of Contents T0. Summary... 3 T1. National profile... 3 T1.1 Drug-related deaths... 3 T1.2 Drug related acute emergencies... 4 T1.3 Drug related infectious
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-FIFTH REGULAR SESSION April 29 - May 1, 2014 Washington, D.C. OEA/Ser.L/XIV.2.55 CICAD/doc.2106/14
More informationFocal Point Ireland: national report for harms and harm reduction
Focal Point Ireland: national report for 2016 - harms and harm reduction Health Research Board. Irish Focal Point to the European Monitoring Centre for Drugs and Drug Addiction Authors of the national
More informationCannabis trends in France TDI data
Cannabis trends in France TDI data Tanja Bastianić High risk drug use and drug treatment in Europe 2014 Lisbon, September 2014 Cannabis in general population in France 2 2 Cannabis in France Cannabis is
More informationORGANIZATION OF AMERICAN STATES
ORGANIZATION OF AMERICAN STATES INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION FIRST INTER-REGIONAL FORUM OF EU-LAC CITIES: PUBLIC POLICIES IN DRUG TREATMENT April 2 5, 2008 Santo Domingo, Dominican Republic
More informationDrug situation in Greece
16/6/217 INDICATIONS FOR DECLINE IN HCV AND HIV INCIDENCE AMONG PEOPLE WHO INJECT DRUGS IN ATHENS, GREECE Anastasios Fotiou Greek Reitox focal point at the Athens University Mental Health Research Institute
More informationClick for Support REALized
Click for Support REALized Newsletter #1: July 2017 1. Introduction In January 2017, the 2-year Click for Support REALized project (co-funded by the European Commission) with thirteen partner organisations
More informationExpert Peer Review for Carfentanil
Expert Committee on Drug Dependence Thirty-ninth Meeting Geneva, 6-10 November 2017 Expert Peer Review for Carfentanil 1. Comments based on the review report a. Evidence on dependence and abuse potential
More informationCyprus Focal Point Report 2014
2014 NATIONAL REPORT (2013 data) TO THE EMCDDA by the Reitox National Focal Point CYPRUS New Developments, Trends REITOX Contents SUMMARY... 6 Trends by individual drug... 10 PART A: NEW DEVELOPMENTS AND
More informationModels of good practice in drug treatment in Europe. Project group
Models of good practice in drug treatment in Europe ( moretreat 2006329 ) Project group Hamburg, London, Rome, Stockholm, Vienna, Warsaw, Zurich Project duration: 17 months from April 2006 August 2008
More informationFrequently Asked Questions about Supervised Injecting Facilities 24 July 2014
Frequently Asked Questions about Supervised Injecting Facilities 24 July 2014 1 Q: What are Supervised Injecting Facilities? A: These are places where people who inject drugs can go to inject in relative
More informationThe epidemiology of HIV infection in Greece HIV/AIDS reporting system
HIV outbreak in IDUsin Greece Update on situation and responses Anastasios Fotiou, REITOX Focal Point-Greece Foteini Giannou, Office of HIV and STIs, Hellenic Centre for Disease Control and Prevention
More informationNPS Current situation in Czech Republic. RICHTER Jiri, SANANIM
NPS Current situation in Czech Republic RICHTER Jiri, SANANIM Data based on - Annual Report: The Czech Republic 2012 Drug Situation, Prague, September 2013, NFP The estimated number of problem drug users
More informationLegal and institutional framework of combating drugs abuse in the. Republic of Croatia
Government of the Republic of Croatia Legal and institutional framework of combating drugs abuse in the Republic of Croatia 9th EXASS Net meeting Zagreb, 11-12 October 2012 Content of the presentation
More informationFrom Fix to Foil. The Dutch experience in promoting transition away from injecting drug use,
From Fix to Foil The Dutch experience in promoting transition away from injecting drug use, 1991-2009 International Harm Reduction Conference Liverpool, April 2010 John-Peter Kools Contents 1. Dutch context
More informationPresent and potential perspectives for information on alcohol use in the EU
EMCDDA Present and potential perspectives for information on alcohol use in the EU Julian Vicente Luxembourg 7-8 June 2016 CNAPA meeting Topics in this presentation 1.- EMCDDA overview and its work on
More informationNigerian Epidemiological Network on Drug Use (NENDU)
This project is funded by the European Union - 1 - Nigerian Epidemiological Network on Drug Use (NENDU) Experience of piloting drug information systems in Nigeria Global Drug early Warning System (GDEWS)
More informationControlled Substances
Controlled Substances Inspector Henry deruiter #668 Organized Crime Enforcement Bureau Detective Sergeant Doug Bedford #964 Guns, Gangs, Drug Enforcement Unit June 27, 2018 Deeds Speak Presentation Overview
More informationDrug Consumption Rooms Worldwide
Drug Consumption Rooms Worldwide Eberhard Schatz Correlation Network International Network of Drug Consumption Rooms Introduction Overview of the current state of DCR s worldwide Presentation of the INDCR
More informationThe drugs situation in Ireland: an overview of trends from 2005 to 2015.
The drugs situation in Ireland: an overview of trends from 2005 to 2015. July 2017 Geoff Bates Centre for Public Health at Liverpool John Moores University Contents Contents... 1 List of acronyms... 3
More informationThe Challenge of New Psychoactive Substances (NPS) A Presentation for CAD by Dr Des Corrigan October 2015
The Challenge of New Psychoactive Substances (NPS) A Presentation for CAD by Dr Des Corrigan October 2015 New Psychoactive Substances Any substance, natural or synthetic which can produce stimulation or
More informationCOUNTRY REPORT: EPIDEMIOLOGICAL SITUATIONS AND PROJECT ACTIVITIES
COUNTRY REPORT: EPIDEMIOLOGICAL SITUATIONS AND PROJECT ACTIVITIES BIRUTE SEMENAITE, MEDICAL DIVISION OF PRISON DEPARTMENT AT THE MINISTRY OF JUSTICE OF THE REPUBLIC OF LITHUANIA LITHUANIAN PRISONS. BACKGROUND:
More informationClients profile by groups in France Why to use group classification?
Clients profile by groups in France Why to use group classification? Tanja BASTIANIĆ OFDT 3 avenue du Stade de France 93218 Saint-Denis La Plaine cedex Tel : 01 41 62 77 16 Fax : 01 41 62 77 00 www.ofdt.fr
More informationANNUAL REPORT ON THE DRUG PHENOMENA. Commissioned by the European Monitoring Centre on Drugs and Drug Addiction IPDT 1
ANNUAL REPORT ON THE DRUG PHENOMENA 2001 Commissioned by the European Monitoring Centre on Drugs and Drug Addiction Lisboa, Outubro de 2001 IPDT 1 TABLE OF CONTENTS SUMMARY... 4 PART 1 - NATIONAL STRATEGIES:
More informationHepatitis prevention in the context of HIV prevention point work in Latvia
Hepatitis prevention in the context of HIV prevention point work in Latvia Līva Grāmatiņa Centre for disease prevention and control of Latvia 9..205. HIV prevention point network in Latvia: History; Location;
More informationThe role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009
The role of UNODC in working law enforcement agencies to promote harm reduction IHRC, Bangkok, 23 April 2009 Drug control has focused mostly on law enforcement Public health which is the first principle
More informationHorizontal Working Party on Drugs EMCDDA contribution towards a methodological framework for monitoring drugs and prison in Europe
COUNCIL OF THE EUROPEAN UNION Brussels, 15 February 2013 5420/1/13 REV 1 CORDROGUE 7 SAN 19 NOTE from: to: Subject: EMCDDA Horizontal Working Party on Drugs EMCDDA contribution towards a methodological
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative The SCE Narrative is written by the Sentinel Community Epidemiologist (SCE) and provides
More informationAddictions and Lifestyles in Contemporary Europe. Reframing Addictions Project
Addictions and Lifestyles in Contemporary Europe Reframing Addictions Project Responds to a 2009 call in the socioeconomic sciences and the humanities to study s and lifestyles in contemporary European
More informationIn order to do this we want a consistent approach from Sheffield agencies to maximise the impact of this work.
The Citywide response to Spice use in Sheffield Spice use needs a co-ordinated response. Our vision is that all workers in contact with Spice users will have the opportunity to respond to Spice use in
More information8.0 Take Home Naloxone
8.0 Take Home Naloxone 8.1 Population characteristics For the financial year (FY) 2016/17, 721 take home naloxone (THN) kits were issued in the City of Edinburgh. Of the 323 individuals who received naloxone
More informationTri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon. Executive Summary
Tri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon 2016 Executive Summary 20.8 million people in the United States have a substance use disorder (not limited to opioids), equivalent
More informationInformal meeting of the Justice and Home Affairs Ministers Sopot July 2011
Informal meeting of the Justice and Home Affairs Ministers Sopot 18-19 July 2011 New challenges to EU anti-drug policy. I. Introduction Every hour an EU citizen dies of a drug overdose. There are as many
More information59 th Session of Commission on Narcotic Drugs Vienna 14-22March 2016
59 th Session of Commission on Narcotic Drugs Vienna 14-22March 2016 Accepted resolution to take to UNGASS 19-21 April We reiterate our commitment to end by 2030 the epidemics of AIDS and tuberculosis,
More informationHungary Hungary Drug Report 2018
Hungary Hungary Drug Report 218 This report presents the top-level overview of the drug phenomenon in Hungary, covering drug supply, use and public health problems as well as drug policy and responses.
More informationSyntetic opioids and NPS. Håkan Leifman Director
Syntetic opioids and NPS Håkan Leifman Director Cannabis totalt Marijuana Hasch Spice el. likn. Ecstasy Sedatives Cocaine Amphetamine Don't know Others Heroine GHB No answer Experiences of different narcotic
More informationMethamphetamine use in the Czech Republic
Methamphetamine use in the Czech Republic History of methamphetamine 1950s Misuse of psychostimulant medicines (Psychoton) 1960s Misuse phenmetrazine Since 1970s methamphetamine (pervitin) (manufactured
More information